Black Diamond Therapeutics Inc
NASDAQ:BDTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Falcon Gold Corp
F:3FA
|
CA |
|
Post Holdings Inc
NYSE:POST
|
US |
|
R
|
R&B Food Supply PCL
SET:RBF
|
TH |
|
W
|
Wartsila Oyj Abp
XMUN:MTA
|
FI |
Wall St Price Targets
BDTX Price Targets Summary
Black Diamond Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDTX's stock price target?
Price Target
10.05
USD
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Black Diamond Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Operating Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.
What is the Net Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
33%
The compound annual growth rate for Net Income over the next 8 years is 33%.
